S7A:5 Sri response, attainment of low disease activity and safety in patients with systemic lupus treated with atacicept in a phase iib study (address ii)
JT Merril, E Morand, DJ Wallace, A Kao, C Vazquez-Mateo, P Chang, P Fleuranceau-Morel, DA Isenberg
Lupus Science & Medicine Mar 2018, 5 (Suppl 1) A26-A27; DOI: 10.1136/lupus-2018-abstract.42
